Delavirdine labels and packages: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Ahmed Zaghw (talk | contribs)
nocaptcha
4,404 edits
No edit summary
Gerald Chi (talk | contribs)
CMEAdmin, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
17,702 edits
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}


==Labels and Packages==


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RESCRIPTOR (DELAVIRDINE MESYLATE) TABLET [VIIV HEALTHCARE COMPANY] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb28dcd2-c457-4137-9eec-00062e5a601b | publisher =  | date =  | accessdate =  }}</ref>
{|
|[[File:Delaverdine package.JPG|800px|thumb]]
|}


==References==
==References==

Latest revision as of 04:08, 5 January 2014

Delavirdine
RESCRIPTOR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Labels and Packages

References

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Delavirdine_labels_and_packages&oldid=924388"